Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Cholesterol Tests Market Report Overview

The cholesterol tests market size was valued at $3.70 billion in 2023. The cholesterol tests market will grow at a CAGR of more than 1% from 2023 to 2033. A cholesterol test is performed to identify elevated levels of cholesterol present in the blood. Elevated levels of cholesterol in the blood may increase the risk of heart attack, stroke, and peripheral artery disease. The prevalence of hypertension is one of the key market growth drivers.

Cholesterol Tests Market Outlook 2023-2033 ($ Billion)

Buy the Full Report for More Insights on the Cholesterol Tests Market Forecast, Download a Free Sample Report

The cholesterol tests market research report highlights the market behavior that will help identify market trends within in vitro diagnostics therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of cholesterol tests across labs, which will help in identifying untapped market opportunities. The cholesterol tests market model also discusses the detailed impact of COVID-19 on the cholesterol tests market for 2020 and beyond.

Cholesterol Tests Market Dynamics

The market growth is significant due to single cholesterol tests such as LDL and total cholesterol tests. Despite primary participants indicating a preference for multi-parameter cholesterol tests, hospital purchasing data indicates that single cholesterol tests dominate the market. This indicates that while physicians may be recommending multi-parameter cholesterol tests, patients and/or labs may be ordering single cholesterol tests due to their cost-effectiveness. Cholesterol Tests are performed for the diagnosis of diseases, such as Hypertension, Hemorrhagic Stroke, Acute Ischemic Stroke, Angina Pectoris, Heart Failure, and Diabetes Mellitus. The cholesterol tests market will grow world-wide during the forecast period due to the cost-effectiveness of LDL and total cholesterol tests. The primary reasons for strong growth include the increasing prevalence of hypertension, heart failure, Diabetes Mellitus, and Angina Pectoris in North America. The incidence rates of these health conditions are also up in Europe, APAC, SCA, and MEA.

Buy the Full Report for Additional Cholesterol Tests Market Dynamics, Download a Free Sample Report

Cholesterol Tests Market Segments

The key segments in the cholesterol tests market are high-density lipoprotein (HDL) cholesterol tests, low-density lipoprotein (LDL) cholesterol tests, multi-parameter cholesterol tests, and total cholesterol tests. In 2023, the multi-parameter cholesterol tests segment dominated the market share. The segment will continue to dominate the market share during the forecast period.

Cholesterol Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights in the Cholesterol Tests Market, Download a Free Sample Report

Cholesterol Tests Market Segmentation by Regions

The key regions in the cholesterol tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, Asia-Pacific emerged as the leading regional market.

Asia Pacific is expected to observe strong growth during the forecast period due to increasing cardiovascular diseases. An increase in the number of new diagnostic centers and pathological laboratories is contributing to the regional growth in the cholesterol testing products and services.

Buy the Full Report for More Regional Insights in the Cholesterol Tests Market, Download A Free Sample Report

Cholesterol Tests Market – Competitive Landscape

The key companies in the cholesterol tests market are Abbott Laboratories, Danaher Corp, Helena Laboratories Corp, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, Siemens AG, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Sekisui Chemical Ltd, Alfa Wassermann Inc, Merck KGaA, and Sinocare Inc, among others. In 2023, Siemens Healthineers AG accounted for the highest cholesterol tests market share and value.

Cholesterol Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Cholesterol Tests Market, Download a Free Sample Report

Segments Covered in this Report.

Cholesterol Tests Segment Outlook ($ Million, 2015-2033)

• High-Density Lipoprotein (HDL) Cholesterol Tests
• Low-Density Lipoprotein (LDL) Cholesterol Tests
• Multi-parameter Cholesterol Tests
• Total Cholesterol Tests

Cholesterol Tests Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are:

Currently marketed Cholesterol tests market and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Cholesterol tests market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Cholesterol tests market.
• Competitive dynamics insights and trends provided for the Cholesterol tests market.

Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Danaher Corp, Helena Laboratories Corp, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, Siemens AG, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Sekisui Chemical Ltd, Alfa Wassermann Inc, Merck KGaA, Sinocare Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:

• CMO executives who must have a deep understanding of the cholesterol tests marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

• Understand the impact of COVID-19 on cholesterol tests.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving cholesterol tests.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the cholesterol tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific cholesterol tests market from 2015-2033.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.